649719-87-9

Basic information

• Product Name: N-{9-[3-(tert-butyl-dimethyl-silanyloxymethyl)-6-methyl-5,8-dioxo-1,3,3a,6,7,8,9,10,13,14a-decahydro-5H-2,4,14-trioxa-7-aza-cyclopentacyclotridecen-1-yl]-9H-purin-6-yl}-benzamide
• CAS NO: 649719-87-9
• Molecular Weight: 650.807
• Mol File: 649719-87-9.mol

Chemical Properties

• CAS DataBase Reference: N-{9-[3-(tert-butyl-dimethyl-silanyloxymethyl)-6-methyl-5,8-dioxo-1,3,3a,6,7,8,9,10,13,14a-decahydro-5H-2,4,14-trioxa-7-aza-cyclopentacyclotridecen-1-yl]-9H-purin-6-yl}-benzamide(CAS DataBase Reference)
• NIST Chemistry Reference: N-{9-[3-(tert-butyl-dimethyl-silanyloxymethyl)-6-methyl-5,8-dioxo-1,3,3a,6,7,8,9,10,13,14a-decahydro-5H-2,4,14-trioxa-7-aza-cyclopentacyclotridecen-1-yl]-9H-purin-6-yl}-benzamide(649719-87-9)
• EPA Substance Registry System: N-{9-[3-(tert-butyl-dimethyl-silanyloxymethyl)-6-methyl-5,8-dioxo-1,3,3a,6,7,8,9,10,13,14a-decahydro-5H-2,4,14-trioxa-7-aza-cyclopentacyclotridecen-1-yl]-9H-purin-6-yl}-benzamide(649719-87-9)

Safety Data

• Hazardous Substances Data: 649719-87-9(Hazardous Substances Data)

Upstream product

• 126775-28-8 N-[9-(3-allyloxy-5,5,7,7-tetraisopropyl-tetrahydro-1,4,6,8-tetraoxa-5,7-disila-cyclopentacycloocten-2-yl)-9H-purin-6-yl]-N-benzoyl-benzamide 
• 126775-22-2 N6-benzoyl-9-[3,5-(1,1,3,3-tetraisopropyldisiloxane-1,3-diyl)-β-D-ribofuranosyl]adenine 
• 649719-82-4 N-{9-[3-allyloxy-5-(tert-butyl-dimethyl-silanyloxymethyl)-4-hydroxy-tetrahydro-furan-2-yl]-9H-purin-6-yl}-N-benzoyl-benzamide 
• 649719-89-1 N-[9-(3-allyloxy-4-hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-9H-purin-6-yl]-N-benzoyl-benzamide 
• 649719-83-5 N-{9-[3-allyloxy-5-(tert-butyl-dimethyl-silanyloxymethyl)-4-hydroxy-tetrahydro-furan-2-yl]-9H-purin-6-yl}-benzamide 
• 58-61-7 adenosine 
• 18162-48-6 tert-butyldimethylsilyl chloride 
• 98-88-4 benzoyl chloride 
• 649719-86-8 (S)-2-Pent-4-enoylamino-propionic acid (2R,3R,4R,5R)-4-allyloxy-5-(6-benzoylamino-purin-9-yl)-2-(tert-butyl-dimethyl-silanyloxymethyl)-tetrahydro-furan-3-yl ester 

Relevant articles and documents

Synthesis of 2'-O,3'-O bicyclic adenosine analogues using ring closing metathesis

The synthesis of 2'-O,3'-O bicyclic adenosine derivatives is presented as the first examples of a new family of 13-membered ring bicyclic nucleoside analogues. Cyclisation was achieved through ring closing metathesis (RCM) on a diene intermediate using Grubbs' catalyst. The Z and E isomers were purified and characterised.